Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. develop brain
Show results for

Refine by
Date

  • This Year
  • Older

Develop Brain Articles & Analysis

27 news found

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

With the advancement of biotechnology and biological tools, such as diagnostic technology and animal model development, researchers can further investigate the mechanisms related to depression and thereby develop effective therapies targeting depression. Ace Therapeutics Psychiatry Team is committed to supporting scientists in making groundbreaking scientific ...

ByAce Therapeutics


Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry

Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry

Such properties include anti-inflammatory effects, promotion of brain health, and reduction of cardiovascular risk. Regular intake has been demonstrated to reduce symptoms of depression and anxiety, enhance fetal brain development, and lower heart disease risks by managing cholesterol and blood pressure levels. ...

ByAlfa Chemistry


Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

All subjects treated to date have also exhibited improved motor activity and normal brain development, which would not be anticipated in the absence of systemic gene transfer of the GALC gene. ...

ByForge Biologics, Inc.


Forge Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients with Krabbe Disease at the SSIEM Annual Symposium

Forge Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients with Krabbe Disease at the SSIEM Annual Symposium

Through Day 180, the patient exhibited improved motor activity and normal brain development compared to previously reported transplanted patients with Krabbe disease. ...

ByForge Biologics, Inc.


Researchers Have Developed a Brain-Computer Interface That Adds a Soundtrack to Your Life

Researchers Have Developed a Brain-Computer Interface That Adds a Soundtrack to Your Life

Historically, it’s served many important roles in society, from social cohesion to mother-infant bonding to healing,” say researchers who have developed a music-based brain-computer interface (BCI) that helps people struggling with various mental health conditions learn to recognize or become more aware and regain control over their emotions. ...

Byni2o, Inc.


Kallyope Raises $236M Series D Financing to Fuel Expansion of Novel Gut-Brain Axis Therapeutic Programs

Kallyope Raises $236M Series D Financing to Fuel Expansion of Novel Gut-Brain Axis Therapeutic Programs

“Since our inception six years ago, Kallyope has pioneered research on the gut-brain axis and developed a transformational drug discovery platform with speed and ingenuity. ...

ByKallyope Inc.


RTsafe’s core role for the development of German guidelines for a standard, safe and efficient implementation of Single-Isocentric Multi-Focal SRS throughout the country

RTsafe’s core role for the development of German guidelines for a standard, safe and efficient implementation of Single-Isocentric Multi-Focal SRS throughout the country

RTsafe is happy to announce that its PRIME and Pseudopatient 3D phantoms, have been selected by a consortium of high-end German Radiotherapy Institutions – led by the Division of Medical Physics of the Department of Radiation Oncology at the Medical Center of University of Freiburg – towards supporting a study whose results will be used for the development of national ...

ByRTsafe


Type 2 Diabetes And Healthy Food Choices With Cleaner Machine For Environmental

Type 2 Diabetes And Healthy Food Choices With Cleaner Machine For Environmental

We often hear if we choose to exercise and eat properly, our pancreas will thank us by functioning better and reduce our chances of developing Type 2 diabetes. Many of you watching your health will have heard of a list of produce referred to as the "dirty dozen." ...

ByOlansi Healthcare Co.,Ltd


LOK Corporation and Sense Neuro Diagnostics Announce Commercial Partnership Focused on International Market

LOK Corporation and Sense Neuro Diagnostics Announce Commercial Partnership Focused on International Market

(August 17, 2021—Montreal, Canada and Cincinnati, Ohio) LOK Corporation, a manufacturing agent that helps companies develop and manage their international distribution network and Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients today announced a commercial partnership to bring ...

BySense Neuro Diagnostics


atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders

atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders

atai Life Sciences ("atai" or the "Company"), a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a majority stake in Delaware based Psyber, a company dedicated to developing interventions to improve various mental health disorders and induce behavioural changes through ...

Byatai Life Sciences AG


Stem Pharm Awarded $1.7M NIH SBIR Grant for Better Models of the Brain

Stem Pharm Awarded $1.7M NIH SBIR Grant for Better Models of the Brain

Stem Pharm’s model fills a commercial need to accurately reflect the complexity of cell types and important cell-to-cell interactions in the developing brain. It is the most comprehensive commercially available neural model and is particularly differentiated by the ability to study neuroinflammation, important for toxicology studies and implicated in ...

ByStem Pharm, Inc


JAMA Highlights Success of BrainScope`s EEG-based Concussion Index As Reliable Indicator of Concussion

JAMA Highlights Success of BrainScope`s EEG-based Concussion Index As Reliable Indicator of Concussion

JAMA Network Open has published "Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in Diagnosing Concussion Among Athletes," a ground-breaking study on the accuracy of the BrainScope FDA-cleared biomarker, the Concussion Index, to indicate the likelihood and severity of concussive brain injury and to aid in evaluating an athlete's ...

ByBrainScope Company, Inc.


Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other Symptoms

Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other Symptoms

Stewart Campbell, Ph.D., Axial’s Senior Vice President of Research and Development, will present new data from Axial’s Phase 1b/2a study of AB-2004 in male adolescents with autism at The BRAIN Foundation Synchrony 2020 conference Dec. 6. ...

ByAxial Therapeutics Inc.


Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics

Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics

Alzheimer’s awareness month, Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics, November 6th 2019 Optina Diagnostics Optina Diagnostics, a world leading company in retinal imaging and artificial ...

ByOptina Diagnostics


Deepwater Chemicals, Inc. host Oklahoma Governor Kevin Stitt on his Top Ten Cabinet Tour.

Deepwater Chemicals, Inc. host Oklahoma Governor Kevin Stitt on his Top Ten Cabinet Tour.

In both cases iodine is necessary for brain development particularly in human embryos. Adding iodine to salt provides a readily available supplement to the human diet and a way of overcoming iodine deficiency. ...

ByDeepwater Chemicals, Inc.


BrainScope Surpasses Primary Endpoints in Multi-Year Department of Defense-Funded Validation Study for New Concussion Assessment Capability

BrainScope Surpasses Primary Endpoints in Multi-Year Department of Defense-Funded Validation Study for New Concussion Assessment Capability

Department of Defense research contract supporting the development and validation of an objective marker of the presence and severity of concussion. ...

ByBrainScope Company, Inc.


Green spaces linked to improved cognitive development in schoolchildren

Green spaces linked to improved cognitive development in schoolchildren

This new study took place in the context of the EU-funded Barcelona BREATHE project2 which investigates the possible effects of TRAP on brain development in children. In the 36 primary schools taking part in BREATHE, 58% of children aged 7–10 (2 623) agreed to participate. ...

ByEuropean Commission, Environment DG


Lauren Sciences awarded grant by Voices Against Brain Cancer to develop V-Smart Nanomedicine for GBM

Lauren Sciences awarded grant by Voices Against Brain Cancer to develop V-Smart Nanomedicine for GBM

New York, New York, June 30, 2015 -- Lauren Sciences LLC, the private New York biotechnology company developing breakthrough V-Smart™ Nanomedicines for brain diseases, announced today the award of a grant by Voices Against Brain Cancer (VABC). ...

ByLauren Sciences LLC


NRDC Sues EPA to Block New Pesticide That Threatens Monarch Butterflies, Human Health

Chemical maker Dow AgroSciences responded by developing new corn and soybeans resistant to both glyphosate and 2,4-D. ...

ByNatural Resources Defense Council


NRDC Sues EPA to Ban Two Toxic Pesticides in Pet Flea Collars

Due to concerns that the products can harm children’s brains and nervous systems, the agency has severely restricted household use of other known neurotoxic pesticides. ...

ByNatural Resources Defense Council

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT